|
|||||
|
|
The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon-like peptide-1 release |
|
| Authors: | WK Ong FM Gribble F Reimann MJ Lynch MD Houslay GS Baillie BL Furman NJ Pyne |
| Institution: | 1Strathclyde Institute of Pharmacy & Biomedical Sciences, Cell Biology Group, University of Strathclyde, Glasgow, UK;2Cambridge Institute for Medical Research, Addenbrooke''s Hospital, University of Cambridge, Cambridge, UK;3Molecular Pharmacology Group, Institute of Biomedical and Life Sciences, University of Glasgow, University Avenue, Glasgow, UK |
| Abstract: | |
| Keywords: | cAMP dominant negative glucagon-like peptide-1 GLUTag cells H89 PDE4D4 phosphodiesterase rolipram |